ProPhase Labs, Inc. Amortization of Debt Discount (Premium)
ProPhase Labs, Inc. (PRPH) reported Amortization of Debt Discount (Premium) of $5.24 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-06-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-06-01
- ProPhase Labs, Inc. amortization of debt discount (premium) for the quarter ending 2025-12-31 was $3.42M, a 581.87% increase year-over-year.
- ProPhase Labs, Inc. amortization of debt discount (premium) for the quarter ending 2025-09-30 was $964.00K, a 57.00% increase year-over-year.
- ProPhase Labs, Inc. amortization of debt discount (premium) for the quarter ending 2025-06-30 was $477.00K, a 108.30% increase year-over-year.
- ProPhase Labs, Inc. amortization of debt discount (premium) for the quarter ending 2025-03-31 was $372.00K, a 165.71% increase year-over-year.
- ProPhase Labs, Inc. amortization of debt discount (premium) for fiscal 2025 was $5.24M, a 252.59% increase from fiscal 2024.
- ProPhase Labs, Inc. amortization of debt discount (premium) for fiscal 2024 was $1.49M, a 1025.00% increase from fiscal 2023.
- ProPhase Labs, Inc. amortization of debt discount (premium) for fiscal 2023 was $132.00K, a 3200.00% increase from fiscal 2022.
- ProPhase Labs, Inc. amortization of debt discount (premium) for fiscal 2022 was $4.00K, a 20.00% decline from fiscal 2021.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 3 month as first filed | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 6 month as first filed | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 9 month as first filed | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $3.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $4.39M derived: sum of 2 quarters · filed 2026-06-01 | $4.86M derived: sum of 3 quarters · filed 2026-06-01 | $5.24M 10-K · filed 2026-06-01 | |||
| 2025-09-30 | $964.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $1.44M derived: sum of 2 quarters · filed 2025-11-19 | $1.81M 10-Q · filed 2025-11-19 | $2.31M derived: sum of 4 quarters · filed 2026-06-01 | |||
| 2025-06-30 | $477.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $849.00K 10-Q · filed 2025-08-13 | $1.35M derived: sum of 3 quarters · filed 2026-06-01 | $1.97M derived: sum of 4 quarters · filed 2026-06-01 | |||
| 2025-03-31 | $372.00K 10-Q · filed 2025-05-20 | $874.00K derived: sum of 2 quarters · filed 2026-06-01 | $1.49M derived: sum of 3 quarters · filed 2026-06-01 | $1.72M derived: sum of 4 quarters · filed 2026-06-01 | |||
| 2024-12-31 | $502.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $1.12M derived: sum of 2 quarters · filed 2026-06-01 | $1.34M derived: sum of 3 quarters · filed 2026-06-01 | $1.49M 10-K · filed 2026-06-01 | |||
| 2024-09-30 | $614.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $843.00K derived: sum of 2 quarters · filed 2025-11-19 | $983.00K 10-Q · filed 2025-11-19 | $1.00M 10-Q · filed 2024-11-13 | $1.02M derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2024-06-30 | $229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $369.00K 10-Q · filed 2025-08-13 | $381.00K 10-Q · filed 2024-08-14 | $404.00K derived: sum of 3 quarters · filed 2025-08-13 | $457.00K derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $140.00K 10-Q · filed 2025-05-20 | $146.00K 10-Q · filed 2024-05-10 | $175.00K derived: sum of 2 quarters · filed 2025-05-20 | $228.00K derived: sum of 3 quarters · filed 2025-05-20 | $252.00K derived: sum of 4 quarters · filed 2025-05-20 | ||
| 2023-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $88.00K derived: sum of 2 quarters · filed 2025-04-01 | $112.00K derived: sum of 3 quarters · filed 2025-04-01 | $132.00K 10-K · filed 2025-04-01 | |||
| 2023-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $77.00K derived: sum of 2 quarters · filed 2024-11-13 | $97.00K 10-Q · filed 2024-11-13 | $97.00K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $44.00K 10-Q · filed 2024-08-14 | $44.00K derived: sum of 3 quarters · filed 2024-08-14 | $46.00K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $20.00K 10-Q · filed 2024-05-10 | $20.00K derived: sum of 2 quarters · filed 2024-05-10 | $22.00K derived: sum of 3 quarters · filed 2024-05-10 | $23.00K derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $2.00K derived: sum of 2 quarters · filed 2024-03-29 | $3.00K derived: sum of 3 quarters · filed 2024-03-29 | $4.00K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $3.00K derived: sum of 2 quarters · filed 2023-11-13 | $4.00K 10-Q · filed 2023-11-13 | $5.00K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $2.00K 10-Q · filed 2023-08-11 | $3.00K derived: sum of 3 quarters · filed 2023-08-11 | $4.00K derived: sum of 4 quarters · filed 2023-08-11 | |||
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-12 | $2.00K derived: sum of 2 quarters · filed 2023-05-12 | $3.00K derived: sum of 3 quarters · filed 2023-05-12 | $4.00K derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $2.00K derived: sum of 2 quarters · filed 2023-03-29 | $3.00K derived: sum of 3 quarters · filed 2023-03-29 | $5.00K 10-K · filed 2023-03-29 | |||
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.00K derived: sum of 2 quarters · filed 2022-11-10 | $4.00K 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $3.00K 10-Q · filed 2022-08-12 | |||||
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-13 | ||||||
| 2020-12-31 | $1.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |